Furthermore, pharmacologic reversion of PRKD1 methylation with the DNA methyltransferase inhibitor decitabine restored PKD1 expression and reduced tumor invasion and metastasis to lungs in an animal model (Borges et al., 2013). Here, PKD1 is linked to neoplasm.